ABLIVA AB AK revenue breakdown overview

ABLIVA AB AK revenue for the last year amounted to 89.42 k EUR, the most of which — 12.25 k EUR — came from its highest performing source at the moment, Mitochondrial Diseases, the year earlier bringing 2.77 k EUR. The greatest contribution to the revenue figure was made by Sweden — last year it brought ABLIVA AB AK 12.25 k EUR, and the year before that — 2.77 k EUR.